Luminex® 200 RUO System w/xPONENT 4.3

Luminex 200

The Luminex 200 utilizes principles of flow cytometry and is the gold standard for basic multiplexing protein needs. Simultaneously multiplex up to 100 analytes in a single microplate well. Delivers fast and cost-effective bioassay results on many assay formats. The Luminex 200 is compatible with all R&D System Luminex assays and the Quantist Analysis Software.
Luminex 200 RUO System w/xPONENT 4.3
1 Image
Product Details
Citations (8)
Supplemental Products

Luminex® 200 RUO System w/xPONENT 4.3 Summary

Luminex 200

The Luminex 200 sets the standard for multiplexing. The ability to use either magnetic or polystyrene beads makes this instrument a popular choice for laboratories needing greater flexibility.


  • Multiplexing: up to 100 analytes per sample volume (80 on MagPlex microspheres)
  • Dynamic Range (Typical): >3.5 logs
  • Read Time: 96-well plate in < 45 min (up to 12,800 tests/hour)
  • Daily Start-Up/Shut-Down: < 30 min

LX200 Quick Guide

Download and view LX200 instrument and software quick guide for routine setup instructions. For detailed instructions refer to the instrument user manual or the Luminex Xponent software user manual.

LX200 Quick Guide Download

Included with the Luminex 200

Part Number LX200-XPON3.1-RUO
Description Luminex 200 System with xPONENT 4.2
Core Instrument Luminex 200 flow-based bead reader with: Sheath Delivery System; X-Y Platform for 96-well plates; Sample probe-needle; 1L sheath bottle, 1.2L Waste bottle; Sample probe height adjustment kit; Automated Maintenance Plate; Heater Block (96 well plate); Documentation
Available Power Cords (pick one nation) USA, Australia, Brazil, Denmark, Germany, Sweden, France, Belgium, Spain, Switzerland, Israel, UK, Italy, Japan, India, China, S. Africa, Argentina, Korea, Taiwan
Bar-code scanner Optional, at no charge with purchase of new system
Included Software xPONENT 4.2 (3 seats)
Allele-call module (3 seats)
Remote Web Monitoring module (3 seats)
Optional Software (extra charges apply) LIS integration module
Automation interface module
Basic Security Module
21 CFR Part 11 Module (supersedes Basic Security)
Additional seats
Reagents Included LX2R-CAL-K25, qty 1 (separately shipped)
LX2R-PVER-K25, qty 1 (separately shipped)
xMAP Sheath Fluid (20L), qty 1 (ships with LX200)
Desktop PC with Win 7 32-bit, US English & xPONENT 4.2 Dell Optiplex with 2 Port PCI RS232 Serial Adapter Card
Dell Warranty Transfer
Dell 17” LCD monitor
Dell Keyboard & mouse
Luminex 200 Reagents

Luminex 100/200 Reagents

The Luminex 100 and Luminex 200 instruments require sheath fluid to serve as the delivery medium to transport the beads to the instrument’s optics. Both instruments have the option of a 20L disposable external sheath fluid container or a compact 20X sheath fluid concentrate pack; which can be reconstituted, with water, to a working volume of 20L when needed. The Luminex 100/200 instruments, operating on xPONENT software, are calibrated using a calibration and a verification kit, each providing 25 uses.


Shipping Conditions
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Store the unopened product at room temperature. Do not use past expiration date.

Product Datasheets

You must select a language.

Product Specific Notices
Luminex® and Luminex® 100/200™ are registered trademarks of Luminex Corporation.

Citations for Luminex® 200 RUO System w/xPONENT 4.3

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

8 Citations: Showing 1 - 8
Filter your results:

Filter by:

  1. Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study
    Authors: RMM Gynthersen, M Ørbæk, H Mens, C Stenør, L Wiese, SR Ostrowski, SD Nielsen, AM Lebech
    Ticks and tick-borne diseases, 2022-10-21;14(1):102057.  2022-10-21
  2. Plasma CD16+ Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+ Adults on Combination Antiretroviral Therapy
    Authors: EG Marques de, X Deng, J Liu, SA Bowler, CM Shikuma, M Stone, PW Hunt, LC Ndhlovu, PJ Norris
    MBio, 2022-04-18;0(0):e0300521.  2022-04-18
  3. Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group
    Authors: X García-Del, I Durán, JL Perez-Grac, M Ángel Clim, B Mellado, JA Virizuela, DE Castellano, A González D, I García Car, C Álvarez-Fe, J García-Don, M Gil-Martin, AG Hernández
    Clinical genitourinary cancer, 2022-03-18;0(0):.  2022-03-18
  4. Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent manner
    Authors: ML Watzenboec, B Drobits, S Zahalka, AD Gorki, A Farhat, F Quattrone, A Hladik, K Lakovits, GM Richard, T Lederer, B Strobl, GA Versteeg, L Boon, P Starkl, S Knapp
    PloS Pathogens, 2021-04-27;17(4):e1009487.  2021-04-27
  5. HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
    Authors: Q Zheng, X Chen, R Han, J Zhu, H Wang, L Chen, Y Song, L Chen, H Cheng, N Jin
    Journal of Cancer, 2021-01-18;12(6):1722-1728.  2021-01-18
  6. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
    Authors: MS Buckland, JB Galloway, CN Fhogartaig, L Meredith, NM Provine, S Bloor, A Ogbe, WM Zelek, A Smielewska, A Yakovleva, T Mann, L Bergamasch, L Turner, F Mescia, EJM Toonen, CP Hackstein, HD Akther, VA Vieira, L Ceron-Guti, J Periselner, S Kiani-Alik, S Grigoriado, D Vaghela, SE Lear, ME Török, WL Hamilton, J Stockton, J Quick, P Nelson, M Hunter, TI Coulter, L Devlin, CITIID-NIH, MRC-Toxico, JR Bradley, KGC Smith, WH Ouwehand, L Estcourt, H Harvala, DJ Roberts, IB Wilkinson, N Screaton, N Loman, R Doffinger, PA Lyons, BP Morgan, IG Goodfellow, P Klenerman, PJ Lehner, NJ Matheson, JED Thaventhir
    Nature Communications, 2020-12-14;11(1):6385.  2020-12-14
  7. Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
    Authors: A Kulukian, P Lee, J Taylor, R Rosler, P de Vries, D Watson, A Forero-Tor, S Peterson
    Mol. Cancer Ther., 2020-04-01;19(4):976-987.  2020-04-01
  8. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
    Authors: B Farkas, F Boldizsar, N Bohonyi, N Farkas, S Marczi, GL Kovacs, J Bodis, M Koppan
    J Ovarian Res, 2020-03-05;13(1):25.  2020-03-05


No product specific FAQs exist for this product, however you may

View all Luminex Instrumentation FAQs

Reviews for Luminex® 200 RUO System w/xPONENT 4.3

There are currently no reviews for this product. Be the first to review Luminex® 200 RUO System w/xPONENT 4.3 and earn rewards!

Have you used Luminex® 200 RUO System w/xPONENT 4.3?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review